Home > Education Hub > News
Learn about Alira Health’s 2026 Global Biosimilars Market Midyear Review, released today, and the regulatory and competitive shifts highlighted in its findings.
The AXIS Registry enrolls its first 100 participants living with myasthenia gravis, a key milestone advancing patient-centered research in autoimmune neurological diseases.
Alira Health is pleased to have acted as Vendor Due Diligence Advisor to Mindful Capital Partners, an independent cross-border private equity firm focused on mid-market companies across Italy and the
Alira Health today announced the Annabel de Maria Memorial Scholarship Program, an annual initiative created to continue the legacy of Annabel de Maria, who served as the company’s Chief Patient
Alira Health, a global healthcare consultancy, today released the 2026 Biologics Contract Manufacturing Report, its annual analysis of the global contract development and manufacturing organization (CDMO) market.
Alira Health today announced its partnership with Patient Focused Medicines Development (PFMD), a coalition dedicated to enabling patient engagement by providing the frameworks and collaborative networks needed to make patient-centered
